Temporal variability of atrial fibrillation in pacemaker recipients for bradycardia: Implications for crossover designed trials, study sample size, and identification of responder patients by means of arrhythmia burden

Journal of Cardiovascular Electrophysiology

Volumn 18, Issue 3, 2007, Pages 250-257

  Botto, Giovanni Luca ^a   Santini, Massimo ^b   Padeletti, Luigi ^c   Boriani, Giuseppe ^d   Luzzi, Gianni ^e   Zolezzi, Francesco ^f   Orazi, Serafino ^g   Proclemer, Alessandro ^h   Chiarandà, Giacomo ⁱ   Favale, Stefano ^e   Solimene, Francesco ^j   Luzi, Mario ^a   Vimercati, Marco ^k   DeSanto, Tiziana ^k   Grammatico, Andrea ^k  

^a SANT ANNA HOSPITAL   (Italy)

^b SAN FILIPPO NERI HOSPITAL   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e POLICLINICO   (Italy)

^f Ospedale Civile   (Italy)

^g SAN CAMILLO DE LELLIS HOSPITAL   (Italy)

^h SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

ⁱ Muscatello Hospital   (United States)

^j Cardiology Department   (Italy)

^k Medtronic Italia   (Italy)

more..

Author keywords

Atrial fibrillation; Pacing therapies; Tachyarrhythmia; Trials

Indexed keywords

AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; BRADYCARDIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HEART PACING; HUMAN; MAJOR CLINICAL STUDY; MALE; MONTE CARLO METHOD; PRIORITY JOURNAL; SUPRAVENTRICULAR TACHYCARDIA;

AGED; ATRIAL FIBRILLATION; BRADYCARDIA; CARDIAC PACING, ARTIFICIAL; CLINICAL TRIALS; COST OF ILLNESS; CROSS-OVER STUDIES; FEMALE; HUMANS; MALE; MONTE CARLO METHOD; PROSPECTIVE STUDIES; RESEARCH DESIGN; SAMPLE SIZE; TIME FACTORS;

EID: 33846953879     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2006.00731.x     Document Type: Article

References (26)

1. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG: Prevalence, age distribution and gender of patients with atrial fibrillation: Analysis and implications. Arch Intern Med 1995;155:469-473.
2. Gajewski J, Singer RB: Mortality in an insured population with atrial fibrillation. JAMA 1981;245:1540-1544.
3. American Heart Association, 1998. Heart and Stroke statistical update, 1997.1999;11:891-894.
4. Wattigney WA, Mensah GA, Croft JB: Increasing trends in hospitalization for atrial fibrillation in United States, 1985 through 1999: Implications for primary prevention. Circulation 2003;108:711-716.
5. Connolly SJ, Kerr CR, Gent M, Roberts RS, Yusuf S, Gillis AM, Sami MH, Talajic M, Tang ASL, Klein GJ, Lau C, Newman DM: Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes.NEngl JMed 2000;342:1385-1391.
6. Lee MA, Weachter R, Pollak S, Kremers MA, Naik AM, Silverman R, Tuzi J, Wang W, Johnson LJ, Euler DE: The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency results of a randomized trial in patients with bradycardia and atrial tachyarrhythmias. J Am Coll Cardiol 2003;41:1926-1932.
7. Carlson MD, Ip J, Messenger J, Beau S, Kalbfleisch S, Gervais P, Cameron DA, Duran A, Val-Mejias J, Mackall J, Gold M: A new pacemaker algorithm for the treatment of atrial fibrillation. Results of the atrial dynamic overdrive pacing trial (ADOPT). J Am Coll Cardiol 2003;42:627-633.
8. Padeletti L, Purerfellner H, Adler S, Waller TJ, Harvey M, Horvitz L, Holbrook R, Kempen K, Mugglin A, Hettrick DA: Combined efficacy of atrial septal lead placement and atrial pacing algorithms for prevention of paroxysmal atrial tachyarrhythmia. J Cardiovasc Electrophysiol 2003;14:1189-1195.
9. Friedman PA, Dijkman B, Warman EN, Xia HA, Mehra R, Stanton MS, Hammill SC: Atrial therapies reduce atrial arrhythmia burden in defibrillator patients. Circulation 2001;104:1023-1028.
10. Page RL, Eilkinson WE, Clair WK, McCarthy EA, Pritchett EL: Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation 1994;89:224-227.
11. Glotzer TV, Hellkamp AS, Zimmerman J, Sweeney MO, Yee R, Marinchak R, Cook J, Paraschos A, Love J, Radoslovich G, Lee KL, Lamas GA: Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke. Circulation 2003;107:1614-1619.
12. Capucci A, Santini M, Padeletti L, Gulizia M, Botto GL, Boriani G, Ricci R, Favale S, Zolezzi F, Di Belardino N, Molon G, Drago F, Villani GQ, Mazzini E, Vimercati M, Grammatico M: Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers. J Am Coll Cardiol 2005;46:1913-1920.
13. Ricci R, Santini M, Puglisi A, Azzolini P, Capucci A, Pignalberi C, Boriani G, Botto GL, Spampinato A, Bellocci F, Proclemer A, Grammatico A, de Seta F: Impact of consistent atrial pacing algorithm on premature atrial complexe number and paroxysmal atrial fibrillation recurrences in brady-tachy syndrome: A randomized prospective cross-over study. J Interv Electrophysiol 2001;5:33-44.
14. Padeletti L, Pieragnoli P, Ciapetti C, Colella A, Musilli N, Porciani MC, Ricci R, Pignalberi C, Santini M, Puglisi A, Azzolini P, Spampinato A, Martelli M, Capucci A, Boriani G, Botto G, Proclemer A: Randomized crossover comparison of right atrial appendage pacing versus interatrial septum pacing for prevention of paroxysmal atrial fibrillation in patients with sinus bradycardia. Am Heart J 2001;142:1047-1055.
15. Kale M, Bennett DH: Pacemaker prevention therapies for the control of drug-refractory paroxysmal atrial fibrillation. Europace 2003;5:123-131.
16. Funck RC, Adamec R, Lurje L, Capucci A, Ritter P, Shekan D, Slegers LC, Tavernier R, Ishikawa T: Atrial overdriving is beneficial in patients with atrial arrhythmias: First results of the PROVE Study. Pacing Clin Electrophysiol 2000;23(Pt. II):1891-1893.
17. Padeletti L, Santini M, Boriani G, Botto GL, Capucci A, Gulizia M, Ricci R, Spampinato A, Pieragnoli P, Warman EN, Vimercati M, Grammatico M: Temporal variability of atrial tachyarrhythmia burden in bradycardia-tachycardia syndrome patients. Eur Heart J 2005;26:165-172.
18. Warman EN, Grammatico A, Padeletti L: Sample size estimates for atrial fibrillation endpoints. Heart Rhythm 2004;1:B58-B63.
19. Gregoratos G, Cheitlin MD, Conill A, Epstein AE, Fellows C, Ferguson TB, Freedman RA, Hlatky MA, Naccarelli GV, Salsena S, Schlant RC, Silka MJ: ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: Executive summary - A report of the american college of cardiology/american heart association task force on practice guidelines (Committee on Pacemaker Implantation). Circulation 1998;97:1325-1335.
20. Israel CW, Hugl B, Unterberg C, Lawo T, Kennis I, Hettrick D, Hohnloser SH: Pace-termination and pacing for prevention of atrial tachyarrhythmias: Results from a multicenterstudy with an implantable device for atrial therapy. J Cardiovasc Electrophysiol 2001;12:1121-1128.
21. Wilkoff BL, Kuhlkamp V, Volosin K, Ellenbogen K, Waldecker B, Kacet S, Gillberg JM, DeSouza CM: Critical analysis of dual-chamber implantable cardioverter-defibrillator arrhythmia detection: Results and technical considerations. Circulation 2001;23;103:381-386.
22. Swerdlow CD, Schöls W, Dijkman B, Jung W, Sheth NV, Olson WH, Gunderson BD: Detection of atrial fibrillation and flutter by a dual chamber implantable cardioverter-defibrillator. Circulation 2000;101:878-885.
23. Kalos MH, Whitlock PA: Monte Carlo Methods. New York: Wiley, 1986.
24. Efron B, Tibshirani R: Bootstrap methods for standard errors, confidence intervals and other methods of statistical accuracy. Stat Sci 1986;1:54-75.
25. Israel CW, Gronefeld G, Ehrlich JR, Li Y-G, Hohnloser SH: Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device. J Am Coll Cardiol 2004;4347-4352.
26. Pocock SJ: Clinical Trials: A Practical Approach. New York, NY: John Wiley and Sons, 1983; p. 110.